ReachMD

Be part of the knowledge.™

Pathology and Laboratory Medicine

159

LikeLikedUnlike

Episodes 1-15 of 20

- Jeffrey S. Weber, MD, PhD
  Peer
3
CME/CE
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
Kimberly’s Concerning Mole: Exploring First-Line Treatment Strategies for Patients with Advanced Metastatic Melanoma
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Pelin Cinar, MD, MS
  Peer
- Malika Fair, MD, MPH, FACEP
  Peer
6
CME/CE
The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities
The COVID-19 Chronicles: Real-World Perspectives on Cancer Care, Emergency Medicine and Healthcare Disparities
1.00 credits
- Stephen Cohen, MD
  Peer
- Thomas C. Wright, Jr., MD
  Peer
9
CME/CE Broadcast Replay
Advances in Cervical Cancer Screening
Advances in Cervical Cancer Screening
0.50 credits
- Kevin Brown, MD
  Peer
- Kevin R. Flaherty, MD
  Peer
- Rebecca C. Keith, MD
  Peer
6
CME/CE Broadcast Replay
Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype
Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype
1.00 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
5
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era
1.00 credits
- Karen Reckamp, MS, MD
  Peer
- Heather Wakelee, MD
  Peer
7
CME/CE
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
Optimizing Patient Outcomes in Advanced NSCLC in a Rapidly Evolving Treatment Era: A Video-based Patient Case Series
0.50 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
7
CME/CE
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part II: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
8
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
6
CME/CE
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
Latest Clinical Advances in the Treatment of BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
14
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Sara Hurvitz, MD
  Peer
- Jacob Sands, MD
  Peer
8
CME/CE
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
Clinical Considerations for Targeted Therapies Across Multiple Tumor Types
0.25 credits
- Robert Mocharnuk, MD
  Peer
- Hossein Borghaei, MS, DO
  Peer
4
CME/CE
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
Part I: Precision Medicine in NSCLC—Implications for Molecular Testing and Treatment
0.50 credits
- Ana Ferreira Castro, MD
  Peer
- Gilberto de Castro Junior, MD, PhD
  Peer
- Zujun Li, MD
  Peer
- Ricard Mesia, MD, PhD
  Peer
4
CME/CE
Clinical Considerations in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical Considerations in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
0.25 credits
- Jyoti D. Patel, MD, FASCO
  Peer
- Kai He, MD, PhD
  Peer
- Gilberto de Lima Lopes Junior, MD, MBA, FAMS
  Peer
3
CME/CE
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Perspectives
Keeping Pace with Immunotherapy Advances in Non-Small Cell Lung Cancer: Global Perspectives
0.25 credits
- Stephen M. Cohen, MD, FACOG
  Peer
- Thomas C. Wright, Jr., MD
  Peer
16
CME/CE
Addressing Unmet Needs in Triage Options During Cervical Cancer Screening
Addressing Unmet Needs in Triage Options During Cervical Cancer Screening
0.25 credits

Loading...

Programs 1/21/21

Segment Chapters

Playlist:

Recommended